Major Melbourne study a world-first for AMD

An Australian-led study has received $5 million to undertake the world’s most intensive investigation into why a particular group of age-related macular degeneration (AMD) patients are at greater risk of vision loss. Read more

BHVI strengthens East Asia presence in new deal

Epidemiological studies and clinical trials involving optical devices for myopia will be the focus of a new three-year agreement between the Brien Holden Vision Institute (BHVI) and a leading Chinese eye hospital network. Read more